...BRCA1/2 and PALB2 mutations showed a trend towards improved survival with platinum-containing regimens, although statist...
...BRCA1/2 or PALB2, variants with established therapeutic relevance, while eight (28.6%) carried ATM, FANCA, or FANCM, var...
...BRCA1/2 carriers, and it is supported prospectively by the POSITIVE trial, whose preplanned update at a median follow-up...
Reclassification of variants of uncertain significance in BRCA1/2 impact clinical management, health outcomes, and healt...
Given their defect in homologous recombination, BRCA1-deficient cancers use polymerase theta (POLQ) microhomology-mediat...
...Brca1 fl/fl Gdf9 +/+) and oocyte-specific Brca1 conditional knockout (cKO; Brca1 fl/fl Gdf9 cre/+) mice were treated wit...
...BRCA1-deficient cancer cells, broader cancer dependencies on TRDMT1 remain unclear. Here, a TRDMT1 inhibitor (TRDMT1i) s...
...Brca1 gene, classically known for its tumor-suppressive role in mammary tissue, also plays a crucial role in maintaining...
...BRCA1/PARP, as benchmarks for GNN-based discovery frameworks. Despite encouraging progress, current evidence remains lar...
...BRCA1 deletion mutant analyses suggested that the BRCA1 C‑terminal domain may contribute to the effect of Peme on BRCA1 ...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269